ReviewThe Journal of clinical endocrinology and metabolism2025

Overcoming Disparities in Using SGLT2 Inhibitors for Cardiorenal Protection in Persons With and Without Type 2 Diabetes.

Gwendolyne A Jack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.